Fosamax is a medication prescribed for the treatment of osteoporosis. The drug changes the cycle of bone formation and, as such, helps to slow the process of bone loss and prevent fractures. Unfortunately, recent studies have shown that Fosamax is falling well short of its goal as it may actually be causing bone death and fracture.
The use of Fosamax has been linked to the developments of osteonecrosis of the jaw (ONJ). ONJ is a bone disease of the jaw which prevents the jaw bone from healing properly after an injury (such as dental surgery). Because the bone tissue is unable to properly heal, the exposed jaw tissue is prone to infection or fracture of the jaw.
Additionally, Fosamax has been a reported cause of two rare types of upper leg fractures- subtrochanteric and diaphseal fractures. Both of these types of fractures occur in the femur or thigh bone. An FDA study on the relation between Fosamax and these types of fractures found approximately 94% of people suffering from these rare fractures had been taking Fosamax.
Fosamax may also contribute to the development of esophageal (throat) cancer in its users. The FDA is currently investigating the link between the drug and throat cancer after receiving a total of 34 reports of esophageal cancer from Fosamax users since 1995.
In 2004, Fosamax users started filing lawsuits against Merk, the drug’s manufacturer, claiming that Merk was aware of the bone and cancer dangers of the drug and failed to properly warn consumers of those risks. In support of that claim, information has come to light that in 2008 the FDA made Merk aware of the multiple reports of upper leg fracture, but Merk did not respond or place warnings on Fasomax packaging until 16 months later. There are currently 4,000 Fosamax lawsuits pending across the country, one of which went to trial earlier this month.
If you or someone you know developed fractures, osteonecrosis, or cancer following the use of Fosamax, you may be entitled to recover for your injuries. Please contact the experienced personal injury attorneys at Dolman Law Group, for a free consultation and case evaluation. (833) 606-DRUG .